Electro-acupuncture combined with adjuvant chemotherapy in gastric cancer (EAGER-2): a protocol for a multicenter randomized controlled trial
The EAGER-2 study is a multicenter, participant-blinded, sham-controlled randomized trial designed to validate the efficacy of electro-acupuncture combined with adjuvant chemotherapy in improving disease-free survival and other clinical outcomes for gastric cancer patients following gastrectomy.